High quality biotech news 2022? BioTech Health X brings you the newest quality biotechnology news including breaking news on the latest biotechnology research, emerging companies, biotech acquisitions, funding deals and other industry analysis. Our coverage not only includes study news and site updates from researchers but also financial analysis of the high and low daily market including several of the last market moves, first opening market updates, top share tips and more. Get everything you need delivered straight to your Inbox with our newsletter based on the science research and stories you want to read and follow from our team. Sign up for free today!
The global nerve conduit market is estimated at around 150,000 units as of 2021 and has been growing at a rate of 15 percent per annum*1. The U.S. accounts for about 70 percent of the share, making it the biggest market of its kind in the world. Toyobo plans to feature the product in collaboration with Synovis at conferences held by various societies. At the events, the company plans to present data*2,3 on clinical tests, post-sale surveys and clinical practice it has accumulated since the company started marketing the product in Japan in 2013. The societies to which Toyobo will showcase the product are those holding conferences across the United States, including ASRM, ASSH and the American Society of Plastic Surgeons.
Though clinical trials in the DMD space have progressed, CureDuchenne is aware of the limitations these therapies present. This has driven our global strategy. That’s what FUTURES is going to lay out for the parents and for the families. They’ll see for the first time where we are in gene therapy, the estimate on when these drugs are likely to be approved, and then what’s next. He explained that Adeno-associated virus (AAV) delivery has packing capacity limitations, but Code’s platform does not, which opens the door to formerly impossible investigations. The treatment can be re-dosed, as well. If their technology platform is successful, it has the ability to transform the way we think about delivering much larger gene transcripts and re-dosing.
Get up to date information as researchers study the genetic developments, disease, cancer, DNA, proteins, immune systems, and simultaneously discussing the current virus COVID 19 (SARS COV 2) as international researchers study, target and search for what may be produced and needed for useful new breakthroughs. Topics range from companies focused on cardiovascular disease to gene therapy, regenerative biotechnology, pathogens, tissue regeneration and more. See additional details at biotechhealthx.com.
On the other hand, the Asia Pacific region is expected to undergo massive transformation in terms of the growth of the passive prosthetics market. With the growing incidences of physical disabilities due to accidents or mishaps, the region provides ample growth opportunities for the leading players in the market. Moreover, with the developments in the healthcare infrastructure of the emerging nations such as India and China, passive prosthetics market players are sensing lucrative business opportunities.